Assyro AI

FDA Orange Book · active-ingredient family

Chlorpheniramine maleate; pseudoephedrine hydrochloride

Chlorpheniramine maleate; pseudoephedrine hydrochloride is approved as 5 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

5

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, extended release

ProductApplicantApplicationTEApproved
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATECENT PHARMSNDA 019428Aug 02, 1988
ISOCLORFISONSNDA 018747Mar 06, 1986
CODIMAL-L.A. 12SCHWARZ PHARMANDA 018935Apr 15, 1985
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATEGRAHAM DMNDA 018844Mar 20, 1985
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATEGRAHAM DMNDA 018843Mar 18, 1985

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATEKV PHARMANDA 071455Mar 01, 1989

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Chlorpheniramine maleate; pseudoephedrine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.